Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) P/E ratio
As of 25 September 2026, Cencora, Inc. (COR) trades at a P/E ratio of 22.7×. Over the past ten years it has ranged from 0.0× (September 2021) to 1,035× (March 2015); the current reading is higher than 67% of that period. That is in line with the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 39.0× | 31.24% |
| FY2024 | 29.7× | 42.77% |
| FY2023 | 20.8× | 25.11% |
| FY2022 | 16.6× | 4.11% |
| FY2021 | 16.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 20.2× | 65.68% |
| FY2018 | 12.2× | (72.15%) |
| FY2017 | 43.8× | 268.52% |
| FY2016 | 11.9× | — |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 20.9× | (12.58%) |
| Mar 2026 | 23.9× | (40.59%) |
| Dec 2025 | 40.3× | 3.43% |
| Sep 2025 | 39.0× | 27.23% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 1,035×
Ten-year median
19.4×
Current reading's percentile
67
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| COSM Cosmos Health Inc. compare | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| COR Cencora, Inc. | 22.7× |
| MCK McKesson Corporation compare | 23.1× |
| HSIC Henry Schein, Inc. compare | 25.0× |
| CAH Cardinal Health, Inc. compare | 30.3× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement